Dubai’s pharmaceutical strategy starts to take shape
Dubai’s ambitions to set itself up as a manufacturing base for pharmaceuticals has cleared a key initial milestone.
The “Dubai Industrial Strategy” — of which the pharma push is one of six initiatives — is now firmly in place, after receiving the sign-off from the Executive Council. The task force overseeing pharma will now pursue its short- and medium-term targets to manufacture medicines and allied health care products bearing the “Made in Dubai” stamp. In the short-term, Dubai will look create manufacturing capacities for “super-generics”, where the molecules making up a particular drug can be delivered through multiple ways.
The “Dubai Industrial Strategy” — of which the pharma push is one of six initiatives — is now firmly in place, after receiving the sign-off from the Executive Council. The task force overseeing pharma will now pursue its short- and medium-term targets to manufacture medicines and allied health care products bearing the “Made in Dubai” stamp. In the short-term, Dubai will look create manufacturing capacities for “super-generics”, where the molecules making up a particular drug can be delivered through multiple ways.